New UTI Vaccine Is Pineapple-Flavoured, Oral-Based, And May Prevent Recurring UTIs For Up To 9 Years
A pineapple-flavoured UTI vaccine could prevent recurrent urinary tract infections (UTIs) and fight treatment-resistant bacteria. However, it has ...
Read More
New UTI Vaccine Is Pineapple-Flavoured, Oral-Based, And May Prevent Recurring UTIs For Up To 9 Years
A pineapple-flavoured UTI vaccine could prevent recurrent urinary tract infections (UTIs) and fight treatment-resistant bacteria. However, it has yet to be cleared of widespread usage in Australia, the US, and the UK.
The MV140 vaccine can alleviate the risk of antibiotic resistance in UTIs treated with commonly used antibiotics. The vaccine is orally applied under the tongue, where the stimulus to the oropharyngeal system can trigger a strong immune response in the bladder. Various studies on MV140 have demonstrated its potential benefits to respondents with recurrent UTIs. In 2022, women who received the vaccine only had zero to one instance of UTIs in nine months.
Meanwhile, recent results from a long-term study revealed that 54% of their participants (72 women and 17 men) remained UTI-free for nine years, while the remainder only had fewer and less severe symptoms. Experts suggest that MV140 should now be tested on more complex populations, such as chronic UTIs, children, and immunocompromised individuals.
As of writing, MV140 has yet to be approved in most countries, and there is yet to be an application for the vaccine in Australia’s Therapeutic Goods Administration. However, doctors in Australia can apply to prescribe it to specific patients via the special access scheme or to become an authorised prescriber to multiple patients. The MV140 vaccine is another potential solution, among others such as a rapid-dissolving tablet and a directly-administered cellular vaccine, that also aims to alleviate UTI symptoms without resorting to antibiotic treatments.
Urinary tract infections are among the most common bacterial infections, with more than 50% of women and 20% of men having a UTI at some point in their lifespan. Recurring instances of the infection may also occur in patients, with symptoms appearing at least two times in six months or at least three times in a year.
Rural Med Schools, Placements Seek To Address Doctor Shortages In AU
Rural medical schools and doctor assignments to the country are becoming more prevalent across Australia, a move that the country’s health sector is hoping could help address doc...
Read More
Rural Med Schools, Placements Seek To Address Doctor Shortages In AU
Rural medical schools and doctor assignments to the country are becoming more prevalent across Australia, a move that the country’s health sector is hoping could help address doctor shortages in remote locations.
These trends are part of what appears to be a cultural shift where both doctors and institutions are pursuing more medical professionals to work in rural areas to accommodate healthcare needs in those regions.
Medical schools such as the University of New South Wales now offer medical education opportunities for students through rural medical schools.
Training in general practice, psychiatry, and emergency medicine are the only ones currently available in these institutions, with medical experts hoping more specialty training is covered in the future.
Other medical schools are also encouraging young medical practitioners to consider placements in rural areas. A University of Queensland research in 2023 showed that medical students undergoing 12-week placements in rural areas are around seven times more likely to end up working in remote locations.
New South Wales today has three locations that offer full medical degrees for aspiring doctors. This is a win for the medical field, as NSW has not been able to offer opportunities for studying medicine rurally until 2017. The move is also a push towards addressing concerns stated in a 2022 inquiry into NSW regional health, wherein witnesses in rural areas expressed concerns about having to wait “weeks and months” to see GPs and specialists.
Aussies Encouraged To Make Covid-19 Plans With GP If They Are Vulnerable To Symptoms
Most Australians at a higher risk of Covid-19 don’t have plans with their GP if they are affected by symptoms, according to a new study.
As per Pfizer, 74% o...
Read More
Aussies Encouraged To Make Covid-19 Plans With GP If They Are Vulnerable To Symptoms
Most Australians at a higher risk of Covid-19 don’t have plans with their GP if they are affected by symptoms, according to a new study.
As per Pfizer, 74% of Australians who are more vulnerable to COVID-19 have yet to create a medical plan on how they can recover should they experience symptoms.
Experts from non-profit Street Side Medics urge Australians to speak with their GPs and other appropriate medical professionals to ensure they are cared for, especially if they are medically vulnerable. Australians may become at a higher risk of COVID-19 symptoms if they are: over 50 years old, have existing health conditions such as heart disease, respiratory conditions, diabetes, and if they are immunocompromised.
While Australians are eligible for antiviral medicines to help alleviate COVID-19 effects, they must take them as soon as they test positive for COVID-19 and within five days of the first signs of symptoms. This helps ensure they are eligible for such medication and secure their availability should the need arise.
Whooping Cough Surge in Australia: What You Should Know
Australia is currently grappling with a surge in whooping cough cases, with over 2,799 cases reported in the first three months of 2024. Queensland and New South Wales are the worst affected st...
Read More
Whooping Cough Surge in Australia: What You Should Know
Australia is currently grappling with a surge in whooping cough cases, with over 2,799 cases reported in the first three months of 2024. Queensland and New South Wales are the worst affected states, each recording over 1,000 cases.
Whooping cough, or pertussis, is a highly contagious respiratory disease caused by the bacteria Bordetella pertussis. Initial symptoms mimic those of a common cold, but progress to severe coughing fits often accompanied by a characteristic "whoop" sound.
This disease is particularly dangerous for newborns who haven't yet received vaccinations, but it can affect individuals of any age. Antibiotics are used to treat whooping cough, but prevention through vaccination is key.
Vaccination is recommended for children and pregnant women under the National Immunisation Program, as well as adults who may be in close contact with infants. However, immunity from vaccines can wane over time, necessitating booster shots.
The surge in cases may be attributed to missed vaccinations during the COVID-19 pandemic, leading to reduced immunity in the population. Additionally, the bacteria responsible for whooping cough has been evolving, with some strains becoming resistant to antibiotics.
Current vaccines remain effective against most strains of whooping cough and are essential in limiting the outbreak. Tracking of the evolving strains is crucial for informing future vaccine development.
To protect oneself and the community, it's important to stay up-to-date with vaccinations and to avoid contact with infants if experiencing cold or flu-like symptoms. Regular check-ins with healthcare providers can ensure vaccination status is current and help prevent the spread of this potentially serious disease.